CELG News 86.38 10/17/2014 04:35:58 Celgene Corp (CELG)

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Celgene Corp (CELG) 86.38 $CELG

Final Glance: Biotechnology companies
AP - Thu Oct 16, 5:02PM CDT
NEW YORK (AP) — Shares of some top biotechnology companies were mixed at the close of trading:
GILD: 96.88 (+0.72), AMGN: 130.45 (-0.45), CELG: 86.38 (-0.17)

Agios (AGIO) Rises on Expansion of Phase I Study on AG-221 - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Oct 16, 3:10PM CDT
Agios Pharmaceuticals (AGIO) initiated four expansion cohorts in its ongoing phase I study on AG-221.
MDVN: 92.54 (+2.91), EBS: 21.24 (+0.35), AGIO: 64.93 (-0.30), CELG: 86.38 (-0.17)

Midday Glance: Biotechnology companies
AP - Thu Oct 16, 12:21PM CDT
NEW YORK (AP) — Shares of some top biotechnology companies are mixed at 1 p.m.:
GILD: 96.88 (+0.72), AMGN: 130.45 (-0.45), CELG: 86.38 (-0.17)

Early Glance: Biotechnology companies
AP - Thu Oct 16, 10:35AM CDT
NEW YORK (AP) — Shares of some top biotechnology companies are down at 10 a.m.:
GILD: 96.88 (+0.72), AMGN: 130.45 (-0.45), CELG: 86.38 (-0.17)

A Quick Look at Celgene Corporation's Drug Development Pipeline
Sean Williams, The Motley Fool - Motley Fool - Thu Oct 16, 8:35AM CDT
Source: Dr. Wendy Longo via Flickr . We're taught, as investors, to keep our eyes on the future because the stock market rarely gives much credence to what a business has done in the past. This couldn't be truer when it comes to the...
XLRN: 29.05 (-0.09), CELG: 86.38 (-0.17)

Was Celgene's Crohn's Disease Drug Worth The Price?
at Investor's Business Daily - Wed Oct 15, 4:39PM CDT
Big-cap biotech Celgene made its name as a cancer fighter, but now it's branching out into diseases of the immune system. And one of the biggest tests of this new strategy comes this weekend. At the United European Gastroenterology Week in Vienna,...
JNJ: 96.78 (-1.43), ABBV: 52.90 (-1.73), CELG: 86.38 (-0.17)

Technical Scrutiny on Health Care Sector Stocks - ImmunoGen, Arrowhead Research, Chimerix, Tekmira Pharma, and Celgene
PR Newswire - Wed Oct 15, 8:10AM CDT
Investor-Edge has initiated coverage on the following equities: ImmunoGen Inc. (NASDAQ: IMGN), Arrowhead Research Corporation (NASDAQ: ARWR), Chimerix Inc. (NASDAQ: CMRX), Tekmira Pharmaceuticals Corporation (NASDAQ: TKMR), and Celgene Corporation (NASDAQ: CELG). Free research on these five companies can be accessed at: http://investor-edge.com/register. The US markets on Tuesday, October 14, 2014, ended on a mixed note as the Dow Jones Industrial Average finished at 16,315.19, down 0.04% and the NASDAQ Composite closed at 4,227.17, up 0.32%. The S&P 500 finished the session 0.16% higher at 1,877.70. During the trading session, six out of ten sectors finished on a higher note. The S&P 500 Health Care Sector Index ended the day at 705.81, down 0.76%, whereas the index has advanced 9.89% on YTD basis. Register for your complimentary reports on these five stocks at:
CMRX: 35.40 (+3.22), ARWR: 7.02 (+0.55), IMGN: 8.38 (-0.38), TKMR: 22.81 (-1.09), CELG: 86.38 (-0.17)

Celgene Set to Possibly Rebound After Yesterday's Selloff of 1.14%
Comtex SmarTrend(R) - Tue Oct 14, 3:43PM CDT
Celgene (NASDAQ:CELG) traded in a range yesterday that spanned from a low of $85.62 to a high of $88.99. Yesterday, the shares fell 1.1%, which took the trading range below the 3-day low of $86.55 on volume of 6.5 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.
CELG: 86.38 (-0.17)

After Yesterday's Decline of 1.14%, Celgene Offers Investors Better Value
Comtex SmarTrend(R) - Tue Oct 14, 3:43PM CDT
Celgene (NASDAQ:CELG) traded in a range yesterday that spanned from a low of $85.62 to a high of $88.99. Yesterday, the shares fell 1.1%, which took the trading range below the 3-day low of $86.55 on volume of 6.5 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.
CELG: 86.38 (-0.17)

Where Will Celgene Corporation Stock Be a Year From Now?
Motley Fool Staff - Motley Fool - Tue Oct 14, 11:20AM CDT
Source: Celgene. The markets have gotten a little panicky lately, so last week we asked some of our top analysts to tell us what they think are the  best companies to buy in a time of tumbling ticker tape . One pick was Celgene , a biotech...
JNJ: 96.78 (-1.43), PFE: 27.70 (-0.49), AMGN: 130.45 (-0.45), CELG: 86.38 (-0.17)

Acquisition, Market Activity, and Upcoming Events - Research Reports on Auxilium, Lakeland, Endo, Actavis and Celgene
PR Newswire - Tue Oct 14, 7:30AM CDT
Today, Analysts Review released its research reports regarding Auxilium Pharmaceuticals Inc. (NASDAQ: AUXL), Lakeland Industries Inc. (NASDAQ: LAKE), Endo International plc (NASDAQ: ENDP), Actavis plc (NYSE: ACT) and Celgene Corporation (NASDAQ: CELG). Private wealth members receive these notes ahead of publication. To reserve complementary membership, limited openings are available at: http://www.analystsreview.com/7148-100free.
ENDP: 60.59 (+0.40), ACT: 222.07 (+4.83), QLTI: 3.99 (+0.03), AUXL: 30.35 (-0.06), LAKE: 20.69 (-2.91), CELG: 86.38 (-0.17), CELGZ: 3.61 (+0.09)

Apple, McKesson Among Big Caps In Trading Range
at Investor's Business Daily - Mon Oct 13, 5:38PM CDT
Many leading stocks have been forming flat bases as the market undergoes a series of fairly shallow pullbacks. In a flat base, a stock corrects 15% or less, with the ideal buy point typically 10 cents above the high of the left side. Leaders holding...
MCK: 185.32 (+0.30), GILD: 96.88 (+0.72), AAPL: 96.26 (-1.28), REGN: 340.71 (+5.96), CELG: 86.38 (-0.17)

Celgene's Otezla Encourages in Plaque Psoriasis at EADV - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon Oct 13, 4:19PM CDT
Celgene (CELG) presented positive data on Otezla at the EADV.
MDVN: 92.54 (+2.91), SHPG: 178.46 (+7.97), REGN: 340.71 (+5.96), CELG: 86.38 (-0.17)

Cheap Stocks Wall Street Loves: Celgene Corporation
Selena Maranjian, The Motley Fool - Motley Fool - Mon Oct 13, 8:00AM CDT
Photo: Celgene Corporation. When looking for promising candidates for your portfolio, it makes sense to seek out undervalued, or cheap, stocks. Analysts on Wall Street do the same, and they slap ratings on thousands of stocks. Ratings are positive...
CELG: 86.38 (-0.17)

SmarTrend Watching for Potential Rebound in Shares of Celgene After 1.58% Loss
Comtex SmarTrend(R) - Fri Oct 10, 4:52PM CDT
Celgene (NASDAQ:CELG) traded in a range yesterday that spanned from a low of $90.87 to a high of $93.85. Yesterday, the shares fell 1.6%, which took the trading range below the 3-day low of $91.54 on volume of 4.8 million shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.
CELG: 86.38 (-0.17)
Scroll down for more posts ▼

Top 10 Most Recent News Articles

UN Integrity Accelerator Targets Corporate Corruption

Updated Category News Views 114

Corruption rarely arrives wearing a villain costume; it shows up as a rushed payment, a friendly intermediary, or a contract nobody wants examined too closely. That is why the United Nations Global Compact's new Business Integrity Accelerator deserves a sober look. Launched November 18, 2026, the programme is not a magic shield, and nobody should sell it as one. But it...

Continue Reading
Term or Whole Life: Costs, Coverage, and Trade-Offs

Updated Category News Views 10

A life insurance choice can sit quietly in a drawer for years, then become brutally important at exactly the wrong moment. Laura Wood's November 18, 2026 comparison of term and whole life insurance is useful for that reason: it keeps dragging the conversation back to the unglamorous stuff that actually matters—how long coverage lasts, what it costs, and whether a...

Continue Reading
Telit Cinterion Tests Its Defense Connectivity Pitch

Updated Category News Views 76

Defense connectivity is a messy business, and Telit Cinterion is leaning straight into the mess at NATO Edge 2026 in Izmir, Turkey. From November 17 through 19, the company is using Booth L86 to show how several wireless links can live inside one mission-focused setup. That may sound like standard trade-show wallpaper, but the underlying problem is very real: military and...

Continue Reading
LLCP Backs Empower in UK Infrastructure Services Push

Updated Category News Views 31

A majority cheque has landed in a business built around unglamorous work that cannot be wished away: keeping mechanical and electrical systems installed, refurbished and maintained. On November 18, LLCP said it completed a majority investment in London-headquartered Empower Technical Services alongside chief executive Nicholas Manning, co-founders Florian Kronawitter and...

Continue Reading
BKV Energy's $400,000 Loyalty Bet Has a Real Point Behind It

Updated Category News Views 13

Retail power customers rarely send thank-you notes; they switch plans, complain about bills, or quietly vanish. That is why BKV Energy putting more than $400,000 into its third annual ElectroShare payout deserves a harder look than the usual feel-good loyalty announcement. A Retention Expense With Some Teeth The payout has climbed quickly: roughly $113,000 in the first...

Continue Reading
Pacific Surfliner Faces Thanksgiving Capacity Test

Updated Category News Views 49

Thanksgiving traffic on Southern California freeways is its own yearly punishment, and the Pacific Surfliner is making a sensible pitch: leave the car parked and let the coast roll past the window. For travelers, that can be a real relief. For anyone watching public transportation, this is also a useful little stress test of whether a busy state-supported rail corridor...

Continue Reading
Scribd’s First Safety Report Shows Enforcement at Scale

Updated Category News Views 292

Forty-seven million enforcement actions is not a decorative statistic Scribd finally put some hard numbers on a problem most document platforms prefer to discuss in foggy corporate language. Its first transparency report, covering January through June 2026, says the company took more than 47 million moderation actions across Scribd and Slideshare. That is a hulking...

Continue Reading
Wallstreet Sand Hands Its Massive Permian Plant to Wilbanks

Updated Category News Views 139

A sand plant can brag about acreage and horsepower all day, but frac crews remember who kept material arriving when a completion schedule got ugly. That is the real backdrop to PI Holdings and Wallstreet Sand Co. naming Blaine Wilbanks president of both businesses on November 18, 2026. This is not a ceremonial chair swap. Wallstreet has built an enormous Permian sand...

Continue Reading
DocLinq Takes Aim at Care Gaps Between Office Visits

Updated Category News Views 16

Healthcare's most expensive loose ends often pile up after the appointment ends. DocLinq, launched from Columbia, Maryland, is taking a run at that awkward stretch between office visits, where records sit in separate systems, chronic-care follow-up gets uneven, and patients are expected to remember far more than any human reasonably can. This is not a story about AI...

Continue Reading
AI Gives CPA Firms a New Advisory Staffing Math Today

Updated Category News Views 50

Month-end just got a lot less comfortable for firms living on the clock. Netsurit and Southwestern Talent are pitching the Virtual CFO Platform as a way for CPA firms to turn machine-led analysis into advisory work without first building a costly bench of specialists. That is not a cute workflow tweak. It goes straight at the labor model that has kept plenty of accounting...

Continue Reading

Top 5 Most Recently Viewed Articles

EHang's Progress and Financial Results: Navigating Change

Updated Category News Views 389

EHang Reports Its Third Quarter Financial Performance EHang Holdings Limited (NASDAQ: EH), a leader in advanced air mobility, has recently released its unaudited financial results for the third quarter. The company continues to strive towards maintaining its full-year revenue guidance of RMB500 million. In this article, we will highlight key operational and financial...

Continue Reading
Analysts Revise Procter & Gamble Earnings Forecasts Ahead of Q1 Results

Updated Category News Views 107

Procter & Gamble Earnings Forecast The Procter & Gamble Company (NYSE: PG) is on the verge of releasing its first-quarter earnings results. Analysts have been busy revising their forecasts ahead of this pivotal moment for the company. Expectations Leading to Earnings Analysts predict that Procter & Gamble will report quarterly earnings of $1.90 per share, marking an...

Continue Reading
BLM Engages Advocates in Revolutionary Wild Horse Dialogue

Updated Category News Views 244

BLM Partners with Advocates for Wild Horse Management The Bureau of Land Management (BLM) has taken a significant step by inviting a group of citizen advocates to work together on the management of wild horses and burros. This initiative marks an important moment in wild horse conservation, providing a unique opportunity for open conversation between the BLM and...

Continue Reading
Covenant Logistics Announces New Quarterly Cash Dividend Details

Updated Category News Views 137

Covenant Logistics Declares Quarterly Cash Dividend Covenant Logistics Group, Inc. has officially announced a quarterly cash dividend of $0.07 per share, benefiting both Class A and Class B common stockholders. This dividend decision, made by the Company’s board of directors, demonstrates their commitment to returning value to shareholders and reflects the company's...

Continue Reading
Landsbankinn hf. Prepares for Upcoming Q3 2024 Financial Release

Updated Category News Views 57

Landsbankinn hf. Announces Financial Results Release Date Landsbankinn hf. is gearing up to share its financial outcomes for the third quarter of 2024. This important event is scheduled for a Wednesday, and stakeholders are keenly anticipating the insights this release will bring. What to Expect from the Financial Results Investors are always on the lookout for key...

Continue Reading